Works by Olanow, C. Warren

Results: 164

A Phase I, Randomized, SAD, MAD, and PK Study of Risvodetinib in Older Adults and Parkinson's Disease.

Published in:

Journal of Parkinson's Disease, 2024, v. 14, n. 2, p. 325, doi. 10.3233/JPD-230319

By:

Werner, Milton H.;
Olanow, C. Warren;
McGarry, Andrew;
Meyer, Christopher;
Kruger, Sydney;
Klint, Carl;
Pellecchia, Jacqueline;
Walaker, Shannon;
Ereshefsky, Larry;
Blob, Lawrence;
Hassman, Howard;
Rodriguez, Carlos;
Samara, Emil;
Safirstein, Beth;
Ellenbogen, Aaron

Publication type:

Article

Continuous Subcutaneous Levodopa Delivery for Parkinson's Disease: A Randomized Study.

Published in:

Journal of Parkinson's Disease, 2021, v. 11, n. 1, p. 177, doi. 10.3233/JPD-202285

By:

Olanow, C. Warren;
Espay, Alberto J.;
Stocchi, Fabrizio;
Ellenbogen, Aaron L.;
Leinonen, Mika;
Adar, Liat;
Case, Ryan J.;
Orenbach, Shir Fuchs;
Yardeni, Tami;
Oren, Sheila;
Poewe, Werner

Publication type:

Article

Lewy body–like pathology in long-term embryonic nigral transplants in Parkinson's disease.

Published in:

Nature Medicine, 2008, v. 14, n. 5, p. 504, doi. 10.1038/nm1747

By:

Kordower, Jeffrey H.;
Yaping Chu;
Hauser, Robert A.;
Freeman, Thomas B.;
Olanow, C. Warren

Publication type:

Article

Unilateral stimulation of the subthalamic nucleus in Parkinson disease: a double-blind 12-month evaluation study.

Published in:

Journal of Neurosurgery, 2004, v. 101, n. 1, p. 36, doi. 10.3171/jns.2004.101.1.0036

By:

Germano, Isabelle M.;
Gracies, Jean-Michel;
Weisz, Donald J.;
Winona Tse;
Koller, William C.;
Olanow, C. Warren

Publication type:

Article

A randomized trial of a low-dose Rasagiline and Pramipexole combination (P2B001) in early Parkinson's disease.

Published in:

2017

By:

Olanow, C. Warren;
Kieburtz, Karl;
Leinonen, Mika;
Elmer, Lawrence;
Giladi, Nir;
Hauser, Robert A.;
Klepiskaya, Olga S.;
Kreitzman, David L.;
Lew, Mark F.;
Russell, David S.;
Kadosh, Shaul;
Litman, Pninit;
Friedman, Hadas;
Linvah, Nurit;
the P2B Study Group, for;
The P B Study Group, For

Publication type:

journal article

Targeting α-Synuclein as a therapy for Parkinson's disease: The battle begins.

Published in:

2017

By:

Olanow, C. Warren;
Kordower, Jeffrey H.

Publication type:

journal article

Abolishing the 1-year rule: How much evidence will be enough?

Published in:

2016

By:

Postuma, Ronald B.;
Berg, Daniela;
Stern, Matthew;
Poewe, Werner;
Olanow, C. Warren;
Oertel, Wolfgang;
Marek, Kenneth;
Litvan, Irene;
Lang, Anthony E.;
Halliday, Glenda;
Goetz, Christopher G.;
Gasser, Thomas;
Dubois, Bruno;
Chan, Piu;
Bloem, Bastiaan R.;
Adler, Charles H.;
Deuschl, Günther

Publication type:

journal article

Long-term effects of rasagiline and the natural history of treated Parkinson's disease.

Published in:

2016

By:

Rascol, Olivier;
Hauser, Robert A.;
Stocchi, Fabrizio;
Fitzer‐Attas, Cheryl J.;
Sidi, Yulia;
Abler, Victor;
Olanow, C. Warren

Publication type:

journal article

Sublingual apomorphine (APL-130277) for the acute conversion of OFF to ON in Parkinson's disease.

Published in:

2016

By:

Hauser, Robert A.;
Olanow, C. Warren;
Dzyngel, Bruce;
Bilbault, Thierry;
Shill, Holly;
Isaacson, Stuart;
Dubow, Jordan;
Agro, Albert

Publication type:

journal article

Eldad Melamed 1942-2015: Ave atque--A memorial.

Published in:

2016

By:

Olanow, C. Warren;
Poewe, Werner

Publication type:

Biography

Trophic factors for Parkinson's disease: To live or let die.

Published in:

2015

By:

Olanow, C. Warren;
Bartus, Raymond T.;
Volpicelli‐Daley, Laura A.;
Kordower, Jeffrey H.

Publication type:

journal article

MDS clinical diagnostic criteria for Parkinson's disease.

Published in:

2015

By:

Postuma, Ronald B.;
Berg, Daniela;
Stern, Matthew;
Poewe, Werner;
Olanow, C. Warren;
Oertel, Wolfgang;
Obeso, José;
Marek, Kenneth;
Litvan, Irene;
Lang, Anthony E.;
Halliday, Glenda;
Goetz, Christopher G.;
Gasser, Thomas;
Dubois, Bruno;
Chan, Piu;
Bloem, Bastiaan R.;
Adler, Charles H.;
Deuschl, Günther

Publication type:

journal article

MDS research criteria for prodromal Parkinson's disease.

Published in:

2015

By:

Berg, Daniela;
Postuma, Ronald B.;
Adler, Charles H.;
Bloem, Bastiaan R.;
Chan, Piu;
Dubois, Bruno;
Gasser, Thomas;
Goetz, Christopher G.;
Halliday, Glenda;
Joseph, Lawrence;
Lang, Anthony E.;
Liepelt‐Scarfone, Inga;
Litvan, Irene;
Marek, Kenneth;
Obeso, José;
Oertel, Wolfgang;
Olanow, C. Warren;
Poewe, Werner;
Stern, Matthew;
Deuschl, Günther

Publication type:

journal article

Advances in clinical trials for movement disorders.

Published in:

2015

By:

Kieburtz, Karl;
Olanow, C. Warren

Publication type:

journal article

Levodopa: Effect on cell death and the natural history of Parkinson's disease.

Published in:

Movement Disorders, 2015, v. 30, n. 1, p. 37, doi. 10.1002/mds.26119

By:

Olanow, C. Warren

Publication type:

Article

Four pioneers of L-dopa treatment: Arvid Carlsson, Oleh Hornykiewicz, George Cotzias, and Melvin Yahr.

Published in:

Movement Disorders, 2015, v. 30, n. 1, p. 19, doi. 10.1002/mds.26120

By:

Lees, Andrew J.;
Tolosa, Eduardo;
Olanow, C. Warren

Publication type:

Article

The end of the term.

Published in:

2014

By:

Olanow, C. Warren;
Obeso, Jose A.

Publication type:

Editorial

Reply to: Psychogenic movement disorders: What's in a name?

Published in:

Movement Disorders, 2014, v. 29, n. 13, p. 1699, doi. 10.1002/mds.26042

By:

Fahn, Stanley;
Olanow, C. Warren

Publication type:

Article

Scientific perspectives.

Published in:

2014

By:

Standaert, David G.;
Olanow, C. Warren;
Obeso, José A.

Publication type:

Editorial

Impact factor for 2013.

Published in:

2014

By:

Olanow, C. Warren;
Obeso, Jose A.

Publication type:

Editorial

Peripheral alpha-synuclein and Parkinson's disease.

Published in:

2014

By:

Olanow, C. Warren;
Wakeman, Dustin R.;
Kordower, Jeffrey H.

Publication type:

Editorial

"Psychogenic movement disorders": they are what they are.

Published in:

2014

By:

Fahn, Stanley;
Olanow, C Warren

Publication type:

journal article

'Psychogenic Movement Disorders': They Are What They Are.

Published in:

Movement Disorders, 2014, v. 29, n. 7, p. 853, doi. 10.1002/mds.25899

By:

Fahn, Stanley;
Olanow, C. Warren

Publication type:

Article

"Psychogenic Movement Disorders": They Are What They Are.

Published in:

Movement Disorders, 2014, v. 29, p. 853, doi. 10.1002/mds.25899

By:

Fahn, Stanley;
Olanow, C. Warren

Publication type:

Article

Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease.

Published in:

Movement Disorders, 2014, v. 29, n. 4, p. 454, doi. 10.1002/mds.25844

By:

Berg, Daniela;
Postuma, Ronald B.;
Bloem, Bastiaan;
Chan, Piu;
Dubois, Bruno;
Gasser, Thomas;
Goetz, Christopher G.;
Halliday, Glenda M.;
Hardy, John;
Lang, Anthony E.;
Litvan, Irene;
Marek, Kenneth;
Obeso, José;
Oertel, Wolfgang;
Olanow, C. Warren;
Poewe, Werner;
Stern, Matthew;
Deuschl, Günther

Publication type:

Article

Initiating levodopa therapy for Parkinson's disease.

Published in:

2014

By:

Olanow, C Warren;
Kieburtz, Karl;
Stocchi, Fabrizio

Publication type:

Journal Article

Initiating levodopa therapy for Parkinson's disease.

Published in:

Movement Disorders, 2014, v. 29, n. 3, p. 430, doi. 10.1002/mds.25805

By:

Olanow, C. Warren;
Kieburtz, Karl;
Stocchi, Fabrizio

Publication type:

Article

Movement disorders-a growing journal for a growing field.

Published in:

Movement Disorders, 2014, v. 29, n. 1, p. 1, doi. 10.1002/mds.25812

By:

Olanow, C. Warren;
Obeso, Jose A.

Publication type:

Article

2012 impact factor increases to 4.558.

Published in:

Movement Disorders, 2013, v. 28, n. 8, p. A5, doi. 10.1002/mds.25638

By:

Olanow, C. Warren;
Obeso, Jose A.

Publication type:

Article

Levodopa-induced dyskinesias in the absence of nigrostriatal degeneration.

Published in:

Movement Disorders, 2013, v. 28, n. 8, p. 1023, doi. 10.1002/mds.25533

By:

Bézard, Erwan;
Olanow, C. Warren;
Obeso, José A.

Publication type:

Article

Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease.

Published in:

Movement Disorders, 2013, v. 28, n. 8, p. 1064, doi. 10.1002/mds.25364

By:

Warren Olanow, C.;
Kieburtz, Karl;
Rascol, Olivier;
Poewe, Werner;
Schapira, Anthony H.;
Emre, Murat;
Nissinen, Helena;
Leinonen, Mika;
Stocchi, Fabrizio

Publication type:

Article

The state of the journal-2013.

Published in:

Movement Disorders, 2013, v. 28, n. 3, p. 259, doi. 10.1002/mds.25423

By:

Olanow, C. Warren;
Obeso, Jose A.

Publication type:

Article

Parkinson's Disease and Alpha Synuclein: Is Parkinson's Disease a Prion-Like Disorder?

Published in:

Movement Disorders, 2013, v. 28, n. 1, p. 31, doi. 10.1002/mds.25373

By:

Olanow, C. Warren;
Brundin, Patrik

Publication type:

Article

Obstacles to the Development of a Neuroprotective Therapy for Parkinson's Disease.

Published in:

Movement Disorders, 2013, v. 28, n. 1, p. 3, doi. 10.1002/mds.25337

By:

Stocchi, Fabrizio;
Olanow, C. Warren

Publication type:

Article

The Vatican Meeting on Neuroprotection for Parkinson's Disease.

Published in:

Movement Disorders, 2013, v. 28, n. 1, p. 1, doi. 10.1002/mds.25356

By:

Olanow, C. Warren;
Obeso, Jose A.;
Stocchi, Fabrizio

Publication type:

Article

Stem cells for Parkinson's disease: Advancing science but protecting patients.

Published in:

Movement Disorders, 2012, v. 27, n. 12, p. 1475, doi. 10.1002/mds.25170

By:

Olanow, C. Warren;
Isacson, Ole

Publication type:

Article

A colonic biomarker of Parkinson's disease?

Published in:

Movement Disorders, 2012, v. 27, n. 6, p. 674, doi. 10.1002/mds.25067

By:

Olanow, C. Warren

Publication type:

Article

The significance of defining preclinical or prodromal Parkinson's disease.

Published in:

Movement Disorders, 2012, v. 27, n. 5, p. 666, doi. 10.1002/mds.25019

By:

Olanow, C. Warren;
Obeso, José A.

Publication type:

Article

Technical advances in deep brain stimulation: How far is enough?

Published in:

Movement Disorders, 2012, v. 27, n. 3, p. 341, doi. 10.1002/mds.24965

By:

Alegre, Manuel;
Hallett, Mark;
Olanow, C. Warren;
Obeso, Jose A.

Publication type:

Article

Perampanel, an AMPA antagonist, found to have no benefit in reducing 'off' time in Parkinson's disease.

Published in:

Movement Disorders, 2012, v. 27, n. 2, p. 284, doi. 10.1002/mds.23983

By:

Lees, Andrew;
Fahn, Stanley;
Eggert, Karla M.;
Jankovic, Joseph;
Lang, Anthony;
Micheli, Federico;
Maral Mouradian, M.;
Oertel, Wolfgang H.;
Olanow, C. Warren;
Poewe, Werner;
Rascol, Olivier;
Tolosa, Eduardo;
Squillacote, David;
Kumar, Dinesh

Publication type:

Article

New Sections for Movement Disorders.

Published in:

Movement Disorders, 2011, v. 26, n. 12, p. 2179, doi. 10.1002/mds.24008

By:

Olanow, C. Warren;
Obeso, Jose A.

Publication type:

Article

Differential role of dopamine in emotional attention and memory: Evidence from Parkinson's disease.

Published in:

Movement Disorders, 2011, v. 26, n. 9, p. 1677, doi. 10.1002/mds.23728

By:

Hälbig, Thomas D.;
Assuras, Stephanie;
Creighton, Judy;
Borod, Joan C.;
Tse, Winona;
Frisina, Pasquale G.;
Voustianiouk, Andrei;
Gracies, Jean-Michel;
Olanow, C. Warren

Publication type:

Article

Movement Disorders 2011 - The State of the Journal.

Published in:

Movement Disorders, 2011, v. 26, n. 7, p. 1183, doi. 10.1002/mds.23840

By:

Olanow, C. Warren;
Obeso, Jose A.

Publication type:

Article

Milestones in movement disorders clinical trials: Advances and landmark studies.

Published in:

Movement Disorders, 2011, v. 26, n. 6, p. 1003, doi. 10.1002/mds.23727

By:

Olanow, C. Warren;
Wunderle, Kathryn B.;
Kieburtz, Karl

Publication type:

Article

Parkinson's disease, proteins, and prions: Milestones.

Published in:

Movement Disorders, 2011, v. 26, n. 6, p. 1056, doi. 10.1002/mds.23767

By:

Olanow, C. Warren;
McNaught, K.

Publication type:

Article

Milestones in magnetic resonance imaging and transcranial sonography of movement disorders.

Published in:

Movement Disorders, 2011, v. 26, n. 6, p. 979, doi. 10.1002/mds.23766

By:

Berg, Daniela;
Steinberger, Jonathan D.;
Warren Olanow, C.;
Naidich, Thomas P.;
Yousry, Tarek A.

Publication type:

Article

The Movement Disorders journal-Then and now.

Published in:

Movement Disorders, 2011, v. 26, n. 6, p. 935, doi. 10.1002/mds.23758

By:

Olanow, C. Warren;
Obeso, Jose

Publication type:

Article

Bioactivity of AAV2-neurturin gene therapy (CERE-120): Differences between Parkinson's disease and nonhuman primate brains.

Published in:

Movement Disorders, 2011, v. 26, n. 1, p. 27, doi. 10.1002/mds.23442

By:

Bartus, Raymond T.;
Herzog, Christopher D.;
Chu, Yaping;
Wilson, Alistair;
Brown, Lamar;
Siffert, Joao;
Johnson, Eugene M.;
Olanow, C. Warren;
Mufson, Elliott J.;
Kordower, Jeffrey H.

Publication type:

Article

Movement Disorders - Twenty-Five years . . . and Still Growing.

Published in:

Movement Disorders, 2011, v. 26, n. 1, p. 1, doi. 10.1002/mds.23625

By:

Olanow, C. Warren;
Obeso, Jose A.

Publication type:

Article

Defining disease-modifying therapies for PD-A road map for moving forward.

Published in:

Movement Disorders, 2010, v. 25, n. 12, p. 1774, doi. 10.1002/mds.23288

By:

Warren Olanow, C.;
Kieburtz, Karl

Publication type:

Article